Welltower Inc. $WELL Shares Bought by Venture Visionary Partners LLC

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Venture Visionary Partners LLC raised its holdings in Welltower Inc. (NYSE:WELL - Free Report) by 3.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 85,613 shares of the real estate investment trust's stock after purchasing an additional 3,243 shares during the quarter. Venture Visionary Partners LLC's holdings in Welltower were worth $13,117,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in WELL. Nuveen LLC purchased a new stake in Welltower in the 1st quarter valued at approximately $762,204,000. Northern Trust Corp boosted its holdings in Welltower by 53.5% in the 4th quarter. Northern Trust Corp now owns 8,430,496 shares of the real estate investment trust's stock valued at $1,062,495,000 after purchasing an additional 2,939,229 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Welltower by 14.0% in the 1st quarter. Wellington Management Group LLP now owns 21,289,684 shares of the real estate investment trust's stock valued at $3,261,792,000 after purchasing an additional 2,614,562 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Welltower by 17,343.3% in the 1st quarter. GAMMA Investing LLC now owns 1,738,052 shares of the real estate investment trust's stock valued at $266,287,000 after purchasing an additional 1,728,088 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in Welltower by 9.7% in the 4th quarter. Bank of America Corp DE now owns 18,706,788 shares of the real estate investment trust's stock valued at $2,357,617,000 after purchasing an additional 1,652,611 shares in the last quarter. Hedge funds and other institutional investors own 94.80% of the company's stock.

Welltower Price Performance

Shares of Welltower stock traded up $0.7730 during trading on Thursday, hitting $166.7630. 2,285,140 shares of the company were exchanged, compared to its average volume of 2,533,896. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.44. Welltower Inc. has a fifty-two week low of $116.50 and a fifty-two week high of $171.09. The stock has a market capitalization of $111.54 billion, a price-to-earnings ratio of 94.22, a P/E/G ratio of 1.87 and a beta of 0.93. The firm has a 50 day moving average price of $159.00 and a 200 day moving average price of $152.16.

Welltower (NYSE:WELL - Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.06. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The firm had revenue of $2.55 billion during the quarter, compared to the consensus estimate of $2.49 billion. During the same period in the previous year, the firm posted $1.05 EPS. The company's quarterly revenue was up 39.6% compared to the same quarter last year. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. On average, equities analysts expect that Welltower Inc. will post 4.88 earnings per share for the current fiscal year.

Welltower Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 21st. Investors of record on Tuesday, August 12th will be given a dividend of $0.74 per share. The ex-dividend date is Tuesday, August 12th. This represents a $2.96 annualized dividend and a dividend yield of 1.8%. This is an increase from Welltower's previous quarterly dividend of $0.67. Welltower's payout ratio is presently 167.23%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on WELL shares. Evercore ISI boosted their price target on Welltower from $162.00 to $175.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 30th. Wall Street Zen lowered Welltower from a "hold" rating to a "sell" rating in a research note on Thursday, May 8th. Morgan Stanley boosted their price target on Welltower from $155.00 to $160.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Wells Fargo & Company boosted their price target on Welltower from $158.00 to $175.00 and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Finally, Scotiabank reissued an "outperform" rating on shares of Welltower in a research note on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Welltower presently has an average rating of "Moderate Buy" and a consensus price target of $173.10.

Insider Activity

In related news, Director Andrew Gundlach acquired 20,000 shares of the business's stock in a transaction that occurred on Monday, June 30th. The stock was purchased at an average cost of $151.46 per share, for a total transaction of $3,029,200.00. Following the transaction, the director directly owned 20,000 shares of the company's stock, valued at approximately $3,029,200. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.21% of the stock is owned by corporate insiders.

Welltower Profile

Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.